Humana (HUM) sues U.S. health agencies seeking to reverse a cut to crucial Medicare quality ratings, linked to billions of dollars in revenue, that sent the company’s stock tumbling this month, Bloomberg’s John Tozzi reports. The lawsuit argues that the U.S. Medicare program was “arbitrary and capricious” in how it calculated the metrics for Humana’s health plans.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HUM:
- Cigna revives merger talks with Humana, Bloomberg reports
- Humana rumor highlighted in Betaville alert
- Humana call volume above normal and directionally bullish
- Humana or Privia: KeyBanc Selects the Superior Healthcare Service Stock to Buy
- Humana star shortfall largest in managed care, says Morgan Stanley